Thermo Fisher Scientific Inc (TMO)
516.10
+3.26
(+0.64%)
USD |
NYSE |
Nov 21, 16:00
516.08
-0.02
(-0.00%)
After-Hours: 20:00
Thermo Fisher Scientific Enterprise Value: 226.18B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 226.18B |
| November 20, 2024 | 224.94B |
| November 19, 2024 | 223.51B |
| November 18, 2024 | 220.52B |
| November 15, 2024 | 225.03B |
| November 14, 2024 | 232.66B |
| November 13, 2024 | 236.05B |
| November 12, 2024 | 235.61B |
| November 11, 2024 | 237.97B |
| November 08, 2024 | 239.82B |
| November 07, 2024 | 241.40B |
| November 06, 2024 | 242.85B |
| November 05, 2024 | 243.28B |
| November 04, 2024 | 241.24B |
| November 01, 2024 | 242.18B |
| October 31, 2024 | 237.74B |
| October 30, 2024 | 239.39B |
| October 29, 2024 | 238.30B |
| October 28, 2024 | 240.12B |
| October 25, 2024 | 240.83B |
| October 24, 2024 | 241.97B |
| October 23, 2024 | 249.28B |
| October 22, 2024 | 253.07B |
| October 21, 2024 | 256.50B |
| October 18, 2024 | 258.93B |
| Date | Value |
|---|---|
| October 17, 2024 | 257.99B |
| October 16, 2024 | 255.04B |
| October 15, 2024 | 258.47B |
| October 14, 2024 | 259.72B |
| October 11, 2024 | 257.10B |
| October 10, 2024 | 255.90B |
| October 09, 2024 | 257.99B |
| October 08, 2024 | 256.53B |
| October 07, 2024 | 257.84B |
| October 04, 2024 | 257.74B |
| October 03, 2024 | 258.63B |
| October 02, 2024 | 263.14B |
| October 01, 2024 | 263.22B |
| September 30, 2024 | 265.38B |
| September 27, 2024 | 261.39B |
| September 26, 2024 | 263.27B |
| September 25, 2024 | 255.80B |
| September 24, 2024 | 260.42B |
| September 23, 2024 | 259.84B |
| September 20, 2024 | 261.11B |
| September 19, 2024 | 263.62B |
| September 18, 2024 | 259.75B |
| September 17, 2024 | 259.89B |
| September 16, 2024 | 261.29B |
| September 13, 2024 | 260.15B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
117.17B
Minimum
Mar 23 2020
293.76B
Maximum
Dec 31 2021
221.00B
Average
234.30B
Median
Jul 13 2023
Enterprise Value Benchmarks
| Fonar Corp | 41.17M |
| XWELL Inc | 0.1013M |
| ProPhase Labs Inc | 35.22M |
| Applied DNA Sciences Inc | -8.969M |
| Veracyte Inc | 2.744B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 1.63B |
| Revenue (Quarterly) | 10.60B |
| Total Expenses (Quarterly) | 8.714B |
| EPS Diluted (Quarterly) | 4.25 |
| Gross Profit Margin (Quarterly) | 40.84% |
| Profit Margin (Quarterly) | 15.38% |
| Earnings Yield | 3.09% |
| Operating Earnings Yield | 3.73% |
| Normalized Earnings Yield | 3.198 |